Four pharma joining to present case against IRA

Four pharmaceutical companies are combining forces to fight the Inflation Reduction Act’s Medicare drug price negotiation program.

Zahid Quraishi, a judge in the U.S. District Court for the District of New Jersey Monday agreed to a request from Bristol Myers Squibb Co. (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) and Novartis AG (SIX:NOVN; NYSE:NVS) for the companies to present their arguments in a single hearing. ...